Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression

Biochemical and Biophysical Research Communications

Volumn 431, Issue 4, 2013, Pages 652-657

  Koopmansch, Benjamin ^a   Berx, Geert ^b   Foidart, Jean Michel ^a   Gilles, Christine ^a   Winkler, Rosita ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Breast cancer; E cadherin; EMT; KLF4; Transcriptional regulation; ZEB2

Indexed keywords

DOXYCYCLINE; KRUPPEL LIKE FACTOR 4; SMAD INTERACTING PROTEIN 1; UNCLASSIFIED DRUG; UVOMORULIN; ZEB2 PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BINDING, COMPETITIVE; CADHERINS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; TRANSCRIPTIONAL ACTIVATION;

EID: 84875236715     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.070     Document Type: Article

References (27)

1. Zeisberg M., Neilson E.G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 2009, 119:1429-1437.
2. Berx G., Raspe E., Christofori G., Thiery J.P., Sleeman J.P. Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin. Exp. Metastasis 2007, 24:587-597.
3. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009, 9:265-273.
4. Bonnomet A., Brysse A., Tachsidis A., Waltham M., Thompson E.W., Polette M., Gilles C. Epithelial-to-mesenchymal transitions and circulating tumor cells. J. Mammary Gland Biol. Neoplasia 2010, 15:261-273.
5. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
6. Giroldi L.A., Bringuier P.P., de Weijert M., Jansen C., van Bokhoven A., Schalken J.A. Role of E boxes in the repression of E-cadherin expression. Biochem. Biophys. Res. Commun. 1997, 241:453-458.
7. Remacle J.E., Kraft H., Lerchner W., Wuytens G., Collart C., Verschueren K., Smith J.C., Huylebroeck D. New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. EMBO J. 1999, 18:5073-5084.
8. Verschueren K., Remacle J.E., Collart C., Kraft H., Baker B.S., Tylzanowski P., Nelles L., Wuytens G., Su M.T., Bodmer R., Smith J.C., Huylebroeck D. SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes. J. Biol. Chem. 1999, 274:20489-20498.
9. Comijn J., Berx G., Vermassen P., Verschueren K., van Grunsven L., Bruyneel E., Mareel M., Huylebroeck D., van Roy F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 2001, 7:1267-1278.
10. van Grunsven L.A., Michiels C., Van de Putte T., Nelles L., Wuytens G., Verschueren K., Huylebroeck D. Interaction between Smad-interacting protein-1 and the corepressor C-terminal binding protein is dispensable for transcriptional repression of E-cadherin. J. Biol. Chem. 2003, 278:26135-26145.
11. Yori J.L., Johnson E., Zhou G., Jain M.K., Keri R.A. Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. J. Biol. Chem. 2010, 285:16854-16863.
12. McConnell B.B., Yang V.W. Mammalian Kruppel-like factors in health and diseases. Physiol. Rev. 2010, 90:1337-1381.
13. Bureau C., Hanoun N., Torrisani J., Vinel J.P., Buscail L., Cordelier P. Expression and function of Kruppel like-factors (KLF) in carcinogenesis. Curr. Genomics 2009, 10:353-360.
14. Pandya A.Y., Talley L.I., Frost A.R., Fitzgerald T.J., Trivedi V., Chakravarthy M., Chhieng D.C., Grizzle W.E., Engler J.A., Krontiras H., Bland K.I., LoBuglio A.F., Lobo-Ruppert S.M., Ruppert J.M. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin. Cancer Res. 2004, 10:2709-2719.
15. Yori J.L., Seachrist D.D., Johnson E., Lozada K.L., Abdul-Karim F.W., Chodosh L.A., Schiemann W.P., Keri R.A. Kruppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia 2011, 13:601-610.
16. Shields J.M., Yang V.W. Identification of the DNA sequence that interacts with the gut-enriched Kruppel-like factor. Nucleic Acids Res. 1998, 26:796-802.
17. Garrett-Sinha L.A., Eberspaecher H., Seldin M.F., de Crombrugghe B. A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J. Biol. Chem. 1996, 271:31384-31390.
18. Zhang W., Shields J.M., Sogawa K., Fujii-Kuriyama Y., Yang V.W. The gut-enriched Kruppel-like factor suppresses the activity of the CYP1A1 promoter in an Sp1-dependent fashion. J. Biol. Chem. 1998, 273:17917-17925.
19. Jenkins T.D., Opitz O.G., Okano J., Rustgi A.K. Transactivation of the human keratin 4 and Epstein-Barr virus ED-L2 promoters by gut-enriched Kruppel-like factor. J. Biol. Chem. 1998, 273:10747-10754.
20. Delacroix L., Begon D., Chatel G., Jackers P., Winkler R. Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells. DNA Cell Biol. 2005, 24:582-594.
21. Vandewalle C., Comijn J., De Craene B., Vermassen P., Bruyneel E., Andersen H., Tulchinsky E., Van Roy F., Berx G. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 2005, 33:6566-6578.
22. Zhang W., Geiman D.E., Shields J.M., Dang D.T., Mahatan C.S., Kaestner K.H., Biggs J.R., Kraft A.S., Yang V.W. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J. Biol. Chem. 2000, 275:18391-18398.
23. Vernimmen D., Begon D., Salvador C., Gofflot S., Grooteclaes M., Winkler R. Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression. Biochem. J. 2003, 370:323-329.
24. Bindels S., Mestdagt M., Vandewalle C., Jacobs N., Volders L., Noel A., van Roy F., Berx G., Foidart J.M., Gilles C. Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 2006, 25:4975-4985.
25. Mejlvang J., Kriajevska M., Vandewalle C., Chernova T., Sayan A.E., Berx G., Mellon J.K., Tulchinsky E. Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. Mol. Biol. Cell 2007, 18:4615-4624.
26. Foster K.W., Frost A.R., McKie-Bell P., Lin C.Y., Engler J.A., Grizzle W.E., Ruppert J.M. Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res. 2000, 60:6488-6495.
27. Yu F., Li J., Chen H., Fu J., Ray S., Huang S., Zheng H., Ai W. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 2011, 30:2161-2172.